^
Association details:
Biomarker:B4GALNT1 expression
Cancer:Retinoblastoma
Drug Class:CAR-T immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction

Published date:
12/10/2020
Excerpt:
Native expression of GD2 on RB cells was demonstrated in human RB cell line - Y79RB….Y79RB-Wasabi cells co-cultured with 4SCAR-GD2 T cells demonstrated a significantly higher rate of tumor cell death...Close to 80% of tumor cells were killed by 24 h after co-culture...with the entire cell population had died by 3 days after co-culture...Thus, 4SCAR-GD2 T cells could effectively target and kill RB tumor cells with high specificity.
DOI:
https://doi.org/10.1016/j.tranon.2020.100971